Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000541944 | SCV000196787 | benign | not provided | 2020-10-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23040494, 15689448, no PMID, 24271325, 27535533) |
Eurofins Ntd Llc |
RCV000149936 | SCV000331147 | benign | not specified | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000370345 | SCV000436776 | likely benign | Collagen 6-related myopathy | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000259316 | SCV000436777 | likely benign | Myosclerosis | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Labcorp Genetics |
RCV000990372 | SCV000657155 | benign | Bethlem myopathy 1A | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990372 | SCV001141326 | likely benign | Bethlem myopathy 1A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000541944 | SCV001153591 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | COL6A2: BP4, BS2 |
Broad Center for Mendelian Genomics, |
RCV000990372 | SCV001435223 | benign | Bethlem myopathy 1A | criteria provided, single submitter | research | The heterozygous p.Arg853Gln variant in COL6A2 has been identified in 2 individuals, 1 with Bethlem myopathy and 1 with trisomy 21 and atrioventricular septal defect (PMID: 15689448, 23040494), but has also been identified in >1% of South Asian chromosomes and 4 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for Bethlem myopathy. | |
Fulgent Genetics, |
RCV002505139 | SCV002810856 | likely benign | Bethlem myopathy 1A; Ullrich congenital muscular dystrophy 1A; Myosclerosis | 2022-01-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000541944 | SCV005207701 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004532670 | SCV004727284 | benign | COL6A2-related disorder | 2021-08-19 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |